down arrow

Coral Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE683E01017
  • NSEID:
  • BSEID: 524506
INR
647.00
-23 (-3.43%)
BSENSE

Apr 11, 12:50 PM

BSE+NSE Vol: 1.4 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Coral Laboratories Ltd stock-summary
stock-summary
Coral Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Coral Laboratories Limited (CLL) was established in February, 1997. Carol Labs are into manufacturing of Generic Branded, Nutraceuticals, OTC and Herbal Medicines. The Company produces various pharmaceutical formulations in 3 different locations all over India. It has plants at Daman and Dehradun . The Company was promoted by Navin B Doshi of the DWD group.
Company Coordinates stock-summary
Company Details
SF-206 Silver Oak Complex, BPC Road Vadodara Gujarat : 390020
stock-summary
Tel: 91-022-2500 5245/46
stock-summary
cs@corallab.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Chetan Navinchandra Doshi (51.54%)

Highest Public shareholder

Meeta Samir Sheth (1.84%)

Individual Investors Holdings

21.18%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Sheela R Kamdar
Independent Director
0
Girish Dhameja
Whole-time Director
28.13 lacs
Sushma Shashi Kadkade
Director & CFO
0
Saurabh Shah
Independent Director
0
Ruchi Anjaria
Company Sec. & Compli. Officer
0
Malay Doshi
Independent Director
0
Rajendrasinh Rana
Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Products
89.87
97.19%
Other Operating Revenue
2.60
2.81%
 
97.19
Pharmaceutical Products
2.81
Pharmaceutical Products
2.81
Other Operating Revenue
97.19
Other Operating Revenue
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
23 Cr
(Quarterly Results - Dec 2024)
Net Profit:
6 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 231 Cr (Micro Cap)

stock-summary
P/E

9.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.30%

stock-summary
Debt Equity

-0.49

stock-summary
Return on Equity

15.31%

stock-summary
Price to Book

1.35